Vnitr Lek 2005, 51(11):1228-1231

Prolaktin - významný činitel vztahu mezi neuroendokrinním a imunitním systémem člověka - editorial

C. Dostál1,*, J. Marek2
1 Revmatologický ústav, Praha, ředitel prof. MUDr. Karel Pavelka, DrSc.
2 III. interní klinika 1. lékařské fakulty UK a VFN, Praha, přednosta prof. MUDr. Štěpán Svačina, DrSc., MBA

Received: June 23, 2005; Published: November 1, 2005  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Dostál C, Marek J. Prolaktin - významný činitel vztahu mezi neuroendokrinním a imunitním systémem člověka - editorial. Vnitr Lek. 2005;51(11):1228-1231.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Sternberg H et al. The stress response and the regulation of inflammatory disease. Ann Intern Dis 1992; 117: 854-66. Go to original source... Go to PubMed...
    2. Besedovsky F, del Rey T. Immune - neuroendocrine interactions. Facts andhypothesis. Endocr Rev 1996; 17: 64-102. Go to original source... Go to PubMed...
    3. Blalock JE. A molecular basis for bidirectional communication between the immune and neuroendocrine system. Physiol Rev 1989; 69: 1-32. Go to original source... Go to PubMed...
    4. Szyper-Kravitz M, Zandman-Goddard G, Lahita RG et al. The neuroendocrine-immune interactions in systemic lupus erythematosus: A basic for understanding disease pathogenesis and complexity. Rheum Dis Clin N Am 2005; 31: 161-175. Go to original source... Go to PubMed...
    5. Horseman ND, Yu-Lee LY. Transcriptional regulation by the helix bundle peptide hormones: growth hormone, prolactin, and hematopoietic cytokines. Endocr Rev 1994; 15: 627-632. Go to original source... Go to PubMed...
    6. Berwaer M, Martial JA, Davis JR. Characterization of an up-stream promoter directing extrapituitary expression of the human prolactin gene. Mol Endocrinol 1994; 8: 635-642. Go to original source...
    7. Nagy E, Berczi I. Pituitary dependence of bone marrow function. Br J Haematol 1989; 71: 457-461. Go to original source... Go to PubMed...
    8. Nagy E, Berczi I, Wren GE et al. Immunomodulation by bromcriptine. Immunopharmacology 1983; 6: 231-238. Go to original source... Go to PubMed...
    9. Matera L. Endocrine, paracrine and autocrine actions of prolactin on immune cells. Life Sci 1996; 59: 599-614. Go to original source... Go to PubMed...
    10. Clevenger CV, Freier DO, Kline JB. Prolactin receptor signal transduction in cells of the immune systém. J Endocrinol 1998; 157: 187-197. Go to original source... Go to PubMed...
    11. Bazan JF. A novel family of growth factor receptors: a common binding domain in the growthhormone, prolactin, erythropoietin and IL-6 receptors, and the p75 IL-2 receptor β-chain. Biochem Biophys Res Commun 1989; 164: 788-896. Go to original source... Go to PubMed...
    12. Rui H, Kirken RA, Farrar WL. Activation of receptor-associated tyrosine kinase JAK2 by prolactin. J Biol Chem 1994; 269: 5364-5369. Go to original source...
    13. Clevenger CV, Kline JB. Prolactin receptor signal transduction. Lupus 2001; 10: 706-711. Go to original source...
    14. Khamashta MA, Ruiz-Irastorza G, Hughes GR. Systemic lupus erythematosus flares during pregnancy. Rheum Dis Clin North Am 1997; 23: 15-24. Go to original source... Go to PubMed...
    15. Gutierrez MA, Molina JF, Jara LJ et al. Prolactin and systemic lupus erythematosus: prolactin secretion by SLE lymphocytes and proliferative (autocrine) activity. Lupus 1995; 4: 438-445. Go to original source... Go to PubMed...
    16. Leanos A, Pascoe D, Fraga A et al. Antiprolactin autoantibodies in systemic lupus erythematosus patients with associated hyperprolactinemia. Lupus 1998; 7: 398-406. Go to original source... Go to PubMed...
    17. Mok CC, Lau CS, Lee KW et al. Hyperprolactinemia in males with systemic lupus erythematosus. J Rheumatol 1998; 25: 2357-2365. Go to PubMed...
    18. Jacobi AM, Rohde W, Ventz M et al. Enhanced serum prolactin (PRL) in patients with systemic lupus erythematosus: PRL levels are related to the disease activity. Lupus 2001; 10: 554-563. Go to original source... Go to PubMed...
    19. Jara LJ, Vera-Lastra O, Miranda JM et al. Prolactin in human systemic lupus erythematosus. Lupus 2001; 10: 748-755. Go to original source... Go to PubMed...
    20. Moszkorzová L, Lacinová Z, Marek J et al. Hyperprolactinaemia in patients with systemic lupus erythematosus Clin Exp Rheumatol 2002; 20: 807-812. Go to PubMed...
    21. Mateo L, Nolla JM, Bonnin MR et al. High serum prolactin levels in men with rheumatoid arthritis. J Rheumatol 1998; 25: 2077-2082. Go to PubMed...
    22. Jara LJ, Silveira LH, Cuellar ML et al. Hyperprolactinemia in Reiter's syndrome. J Rheumatol 1994; 21: 1292-1299. Go to PubMed...
    23. Haga HJ, Rygh T. The prevalence of hyperprolactinemia in patients with primary Sjögren's syndrome. J Rheumatol 1999; 26: 1291-1298. Go to PubMed...
    24. Debelic D, Sepcic J, Rudez J et al. Hyperprolactinemia: an unusual initial manifestation of multiple sclerosis. Eur Neurol 1997; 38: 128-135. Go to original source... Go to PubMed...
    25. Azar ST, Yamout B. Prolactin secretion is increased in patients with multiple sclerosis. Endocr Res 1999; 25: 207-212. Go to original source... Go to PubMed...
    26. Yamasaki K, Horiuchi I, Minohara M et al. Hyperprolactinemia in optico-spinal multiple sclerosis. Intern Med 2000; 39: 296-315. Go to original source... Go to PubMed...
    27. Notsu K, Ito Y, Furuya H et al. Incidence of hyperprolactinemia in patients with Hashimoto's thyroiditis. Endocr J 1997; 44: 89-97. Go to original source... Go to PubMed...
    28. Legakis I, Petroyianni V, Saramantis A et al. Elevated prolactin to cortisol ratio and polyclonal autoimmune activation in Hashimoto's thyroiditis. Horm Metab Res 2001; 33: 585-594. Go to original source... Go to PubMed...
    29. Pleyer U, Gupta D, Weidle EG et al. Elevated prolactin levels in human aqueous humor of patients with anterior uveitis. Graefes Arch Clin Ecp Ophthalmol 1991; 229: 447-455. Go to original source... Go to PubMed...
    30. Wollmann HA, Pleyer U, Friedel S et al. Neuroendocrine alterations in uveitis patients. Graefes Arch Clin Exp Ophtahalmol 1994; 232: 297-308. Go to original source... Go to PubMed...
    31. Jacobi AM, Rohde W, Volk HD et al. Prolactin enhances the in vitro production of IgG in peripheral blood mononuclear cells from patients with systemic lupus erythematosus but not from healthy controls. Ann Rheum Dis 2001; 60: 242-302. Go to original source... Go to PubMed...
    32. McMurray RW. Prolactin in murine systemic lupus erythematosus. Lupus 2001; 10: 742-749. Go to original source... Go to PubMed...
    33. Riskind PN, Massacesi L, Doolittle TH et al. The role of prolactin in autoimmune demyelination: suppression of experimental allergic encephalomyelitis by bromocroptine. Ann Neurol 1991; 29: 542. Go to original source... Go to PubMed...
    34. Worwood M, Raha Chowdhury R, Robson KJ et al. The HLA A1-B8 haplotype extends 6 Mb beyond HLA-A: associations between HLA-A, B, F and 15 microsatellite markers. Tissue Antigens 1997; 50: 521. Go to original source... Go to PubMed...
    35. Brennan P, Hajjer A, Ong KR et al. Allelic markers close to prolactin are associated with HLA-DRB1 susceptibility alleles among women with rheumatoid arhritis and systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1383. Go to original source... Go to PubMed...
    36. Stevens A, Ray D, Alansari A et al. Characterization of prolactin gene polymorphism and its associations with systemic lupus erythematosus. Arthritis Rheum 2001; 44: 2358. Go to original source...
    37. Ebers GC, Kukay K, Bulman DE et al. A full genome search in multiple sclerosis. Nat Genet 1996; 13: 472. Go to original source... Go to PubMed...
    38. Sundwall M, Jirholt J, Yang HT et al. Identification of murine loci associated with susceptibility to chronic experimental autoimmune encephalomyelitis. Nat Genet 1995; 10: 313. Go to original source... Go to PubMed...
    39. Oturai A, Larsen F, Ryder LP et al. Linkage and association analysis of susceptibility regions on chromosomes 5 and 6 in 106 Scandinavian sibling pair families with multiple sclerosis. Ann Neurol 1999; 46: 612. Go to original source... Go to PubMed...
    40. Mellai M, Giordano M, D'Alfonso S et al. Prolactin and Prolaktin Receptor Gene Polymorphisms in multiple Sclerosis and Sytemic Lupus Erythematosus: Human Immunology 2003; 64: 274-284. Go to original source... Go to PubMed...
    41. Rovenský J, Imrich R, Malis F et al. Prolactin and growth hormone responses to hypoglycemia in patients with rheumatoid arthritis and ankylosing spondylitis. J Rheumatol 2004; 12: 2418-2421.
    42. Eijsbouts AMM, van den Hoogen FHJ, Laan RFJM et al. Decreased prolactin response to hypoglycaemia in patients with rheumatoid arthritis: correlation with disease activity. Ann Rheum Dis 2005; 64: 433-437. Go to original source... Go to PubMed...
    43. Dostál C, Marek J, Moszkorzová L et al. Effects of stress on serum prolactin levels in patients with systemic lupus erythematosus. Ann NY Acad Sci 2002; 966: 247-251. Go to original source... Go to PubMed...
    44. Dostál C, Moszkorzová L, Musilová L et al. Serum prolactin stress values in patients with systemic lupus erythematosus. Ann Rheum Dis 2003; 62: 487-488. Go to original source... Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.